Published in J Antimicrob Chemother on October 27, 2008
Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections. Nat Rev Microbiol (2011) 2.68
Describing the mechanism of antimicrobial peptide action with the interfacial activity model. ACS Chem Biol (2010) 2.27
The combined transduction of copper, zinc-superoxide dismutase and catalase mediated by cell-penetrating peptide, PEP-1, to protect myocardium from ischemia-reperfusion injury. J Transl Med (2011) 0.99
Chlamydia trachomatis outer membrane complex protein B (OmcB) is processed by the protease CPAF. J Bacteriol (2012) 0.89
Amphipathic β2,2-Amino Acid Derivatives Suppress Infectivity and Disrupt the Intracellular Replication Cycle of Chlamydia pneumoniae. PLoS One (2016) 0.76
Identification of cell-penetrating peptides that are bactericidal to Neisseria meningitidis and prevent inflammatory responses upon infection. Antimicrob Agents Chemother (2013) 0.75
Antimicrobial peptides of multicellular organisms. Nature (2002) 23.50
Interaction of chlamydiae and host cells in vitro. Microbiol Rev (1991) 8.10
Toxoplasma invasion of mammalian cells is powered by the actin cytoskeleton of the parasite. Cell (1996) 5.01
A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated alpha-defensins. Science (1999) 3.90
Purification and chemical composition of reticulate bodies of the meningopneumonitis organisms. J Bacteriol (1967) 3.86
A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat Biotechnol (2001) 3.86
Chlamydial persistence: beyond the biphasic paradigm. Infect Immun (2004) 2.78
Susceptibility of Chlamydia trachomatis to protegrins and defensins. Infect Immun (1996) 2.16
Protective role of magnesium in the neutralization by antibodies of Chlamydia trachomatis infectivity. Infect Immun (1988) 2.11
Homodimeric theta-defensins from rhesus macaque leukocytes: isolation, synthesis, antimicrobial activities, and bacterial binding properties of the cyclic peptides. J Biol Chem (2001) 1.41
Trachoma: transmission, infection, and control. Lancet Infect Dis (2007) 1.25
Chlamydia pneumoniae and atherosclerosis. Cell Microbiol (2004) 1.23
Pneumonia due to Chlamydia pneumoniae: prevalence, clinical features, diagnosis, and treatment. Clin Infect Dis (1995) 1.21
Protegrins: structural requirements for inactivating elementary bodies of Chlamydia trachomatis. Infect Immun (1996) 1.06
Induced expression of melittin, an antimicrobial peptide, inhibits infection by Chlamydia trachomatis and Mycoplasma hominis in a HeLa cell line. Int J Antimicrob Agents (2002) 1.03
Susceptibility of human and murine Chlamydia trachomatis serovars to granulocyte- and epithelium-derived antimicrobial peptides. J Pept Res (2003) 1.02
Synthesis and characterization of indolicidin, a tryptophan-rich antimicrobial peptide from bovine neutrophils. Int J Pept Protein Res (1995) 1.00
In vitro microbicidal activities of cecropin peptides D2A21 and D4E1 and gel formulations containing 0.1 to 2% D2A21 against Chlamydia trachomatis. Antimicrob Agents Chemother (2002) 0.97
Design and mechanism of action of a novel bacteria-selective antimicrobial peptide from the cell-penetrating peptide Pep-1. Biochem Biophys Res Commun (2006) 0.92
Activity of Novispirin G-10, a novel antimicrobial peptide against Chlamydia trachomatis and vaginosis-associated bacteria. Exp Mol Pathol (2003) 0.91
Effect of induced expression of an antimicrobial peptide melittin on Chlamydia trachomatis and Mycoplasma hominis infections in vivo. Biochem Biophys Res Commun (2005) 0.90
Activity of cathelicidin peptides against Chlamydia spp. Antimicrob Agents Chemother (2005) 0.89
A cumulative experience examining the effect of natural and synthetic antimicrobial peptides vs. Chlamydia trachomatis. J Pept Res (2004) 0.85
Sensitivity of Chlamydia suis to cathelicidin peptides. Vet Microbiol (2007) 0.85
Data from UK genitourinary medicine clinics, 2006: a mixed picture. Sex Transm Infect (2007) 0.78
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients. Cancer Cell (2004) 10.89
Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature. Nat Prod Rep (2013) 5.38
Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis. Cancer Cell (2004) 4.17
Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial. Lancet Oncol (2011) 3.95
A test of climate, sun, and culture relationships from an 1810-year Chinese cave record. Science (2008) 3.94
Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns. J Virol (2005) 3.74
Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients. Cancer Prev Res (Phila) (2009) 3.70
Structural basis for the recognition of blood group trisaccharides by norovirus. J Virol (2007) 3.58
Risk factors and outcomes among children admitted to hospital with pandemic H1N1 influenza. CMAJ (2009) 3.11
MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression. J Biol Chem (2010) 2.85
Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis. BMJ (2013) 2.73
MEC-17 is an alpha-tubulin acetyltransferase. Nature (2010) 2.64
FADD and caspase-8 control the outcome of autophagic signaling in proliferating T cells. Proc Natl Acad Sci U S A (2008) 2.52
Antimicrobial peptides from human platelets. Infect Immun (2002) 2.32
Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers. Clin Cancer Res (2004) 2.28
Pandemic influenza in Canadian children: a summary of hospitalized pediatric cases. Vaccine (2010) 1.86
Structural basis for the receptor binding specificity of Norwalk virus. J Virol (2008) 1.82
Guidelines for the prevention and management of community-associated methicillin-resistant Staphylococcus aureus: A perspective for Canadian health care practitioners. Can J Infect Dis Med Microbiol (2006) 1.81
Effect of combined laser acupuncture on knee osteoarthritis: a pilot study. Lasers Med Sci (2008) 1.77
A novel family of Toxoplasma IMC proteins displays a hierarchical organization and functions in coordinating parasite division. PLoS Pathog (2010) 1.70
Cell division in Apicomplexan parasites is organized by a homolog of the striated rootlet fiber of algal flagella. PLoS Biol (2012) 1.67
Epsilon-tubulin is an essential component of the centriole. Mol Biol Cell (2002) 1.64
Burden of seasonal influenza in children with neurodevelopmental conditions. Pediatr Infect Dis J (2014) 1.63
Warburg effect in chemosensitivity: targeting lactate dehydrogenase-A re-sensitizes taxol-resistant cancer cells to taxol. Mol Cancer (2010) 1.50
Criterion for amino acid composition of defensins and antimicrobial peptides based on geometry of membrane destabilization. J Am Chem Soc (2011) 1.48
Open source clinical science for emerging infections. Lancet Infect Dis (2014) 1.47
Genetic and phenotypic characterization of GII-4 noroviruses that circulated during 1987 to 2008. J Virol (2010) 1.46
Neuraminidase inhibitor-rimantadine combinations exert additive and synergistic anti-influenza virus effects in MDCK cells. Antimicrob Agents Chemother (2004) 1.41
Homodimeric theta-defensins from rhesus macaque leukocytes: isolation, synthesis, antimicrobial activities, and bacterial binding properties of the cyclic peptides. J Biol Chem (2001) 1.41
Rapid immune recovery and graft-versus-host disease-like engraftment syndrome following adoptive transfer of Costimulated autologous T cells. Clin Cancer Res (2009) 1.38
Spike protein VP8* of human rotavirus recognizes histo-blood group antigens in a type-specific manner. J Virol (2012) 1.38
Overcoming trastuzumab resistance in breast cancer by targeting dysregulated glucose metabolism. Cancer Res (2011) 1.35
B7-H4 expression associates with cancer progression and predicts patient's survival in human esophageal squamous cell carcinoma. Cancer Immunol Immunother (2011) 1.34
Prediction of antimicrobial peptides based on sequence alignment and feature selection methods. PLoS One (2011) 1.34
alpha-Defensins can have anti-HIV activity but are not CD8 cell anti-HIV factors. AIDS (2003) 1.34
Functional analysis of the heat shock regulator HrcA of Chlamydia trachomatis. J Bacteriol (2002) 1.33
CPAF: a Chlamydial protease in search of an authentic substrate. PLoS Pathog (2012) 1.33
Crystallography of a Lewis-binding norovirus, elucidation of strain-specificity to the polymorphic human histo-blood group antigens. PLoS Pathog (2011) 1.31
Sigma28 RNA polymerase regulates hctB, a late developmental gene in Chlamydia. Mol Microbiol (2003) 1.29
High-dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcoma. Cancer (2004) 1.29
Cryo-EM structure of a novel calicivirus, Tulane virus. PLoS One (2013) 1.26
Zinc and prostate cancer: a critical scientific, medical, and public interest issue (United States). Cancer Causes Control (2005) 1.25
Bovine peptidoglycan recognition protein-S: antimicrobial activity, localization, secretion, and binding properties. J Immunol (2006) 1.24
Mutational analysis of the Chlamydia trachomatis dnaK promoter defines the optimal -35 promoter element. Nucleic Acids Res (2003) 1.24
Interleukin-6 is a potential biomarker for severe pandemic H1N1 influenza A infection. PLoS One (2012) 1.23
Glucose oxidation modulates anoikis and tumor metastasis. Mol Cell Biol (2012) 1.23
Cardiovascular events in patients taking varenicline: a case series from intensive postmarketing surveillance in New Zealand. Drug Saf (2012) 1.21
Stalling the engine of resistance: targeting cancer metabolism to overcome therapeutic resistance. Cancer Res (2013) 1.19
Structure-activity determinants in paneth cell alpha-defensins: loss-of-function in mouse cryptdin-4 by charge-reversal at arginine residue positions. J Biol Chem (2003) 1.19
Isolation, characterization, and antimicrobial properties of bovine oligosaccharide-binding protein. A microbicidal granule protein of eosinophils and neutrophils. J Biol Chem (2002) 1.18
Rotavirus VP8*: phylogeny, host range, and interaction with histo-blood group antigens. J Virol (2012) 1.18
Molecular mechanism of tryptophan-dependent transcriptional regulation in Chlamydia trachomatis. J Bacteriol (2006) 1.17
A pilot study of protracted topotecan dosing using a pharmacokinetically guided dosing approach in children with solid tumors. Clin Cancer Res (2003) 1.17
Microbicidal properties and cytocidal selectivity of rhesus macaque theta defensins. Antimicrob Agents Chemother (2007) 1.13
Mitotic deregulation by survivin in ErbB2-overexpressing breast cancer cells contributes to Taxol resistance. Clin Cancer Res (2009) 1.13
In silico prediction and functional validation of sigma28-regulated genes in Chlamydia and Escherichia coli. J Bacteriol (2006) 1.13
CD137 promotes proliferation and survival of human B cells. J Immunol (2009) 1.12
Replication bypass of the acrolein-mediated deoxyguanine DNA-peptide cross-links by DNA polymerases of the DinB family. Chem Res Toxicol (2008) 1.12
Differential expression of miR-145 in children with Kawasaki disease. PLoS One (2013) 1.12
Genome-wide shRNA screen revealed integrated mitogenic signaling between dopamine receptor D2 (DRD2) and epidermal growth factor receptor (EGFR) in glioblastoma. Oncotarget (2014) 1.11
Human milk contains elements that block binding of noroviruses to human histo-blood group antigens in saliva. J Infect Dis (2004) 1.10
Norovirus P particle efficiently elicits innate, humoral and cellular immunity. PLoS One (2013) 1.10
Emergence of the GII4/2006b variant and recombinant noroviruses in China. J Med Virol (2008) 1.10
Sensitivity of rapid influenza diagnostic testing for swine-origin 2009 a (H1N1) influenza virus in children. Pediatrics (2010) 1.08
Gastrointestinal complications in children with acute myeloid leukemia. Leuk Lymphoma (2010) 1.06
Receptor tyrosine kinase ErbB2 translocates into mitochondria and regulates cellular metabolism. Nat Commun (2012) 1.06
Sparse logistic regression with Lp penalty for biomarker identification. Stat Appl Genet Mol Biol (2007) 1.06
Aly and THO are required for assembly of the human TREX complex and association of TREX components with the spliced mRNA. Nucleic Acids Res (2012) 1.06
Preclinical studies of vorinostat (suberoylanilide hydroxamic acid) combined with cytosine arabinoside and etoposide for treatment of acute leukemias. Clin Cancer Res (2009) 1.05
θ-Defensins: cyclic peptides with endless potential. J Biol Chem (2012) 1.05
Quantitative interactions between cryptdin-4 amino terminal variants and membranes. Peptides (2003) 1.04
Isolation, synthesis, and antimicrobial activities of naturally occurring theta-defensin isoforms from baboon leukocytes. Infect Immun (2008) 1.03
Mutational analysis of the promoter recognized by Chlamydia and Escherichia coli sigma(28) RNA polymerase. J Bacteriol (2006) 1.03
Cyclic and acyclic defensins inhibit human immunodeficiency virus type-1 replication by different mechanisms. PLoS One (2010) 1.03
B7-H3 silencing increases paclitaxel sensitivity by abrogating Jak2/Stat3 phosphorylation. Mol Cancer Ther (2011) 1.03
Emerging metabolic targets in cancer therapy. Front Biosci (Landmark Ed) (2011) 1.02
Testing the annual nature of speleothem banding. Sci Rep (2013) 1.02
A candidate dual vaccine against influenza and noroviruses. Vaccine (2011) 1.01
Downregulation of missing in metastasis gene (MIM) is associated with the progression of bladder transitional carcinomas. Cancer Invest (2007) 1.01
Electroacupuncture activates corticotrophin-releasing hormone-containing neurons in the paraventricular nucleus of the hypothalammus to alleviate edema in a rat model of inflammation. BMC Complement Altern Med (2008) 1.00
beta-Tubulin-II expression strongly predicts outcome in patients receiving induction chemotherapy for locally advanced squamous carcinoma of the head and neck: a companion analysis of the TAX 324 trial. J Clin Oncol (2009) 1.00
Association of histo-blood group antigens with susceptibility to norovirus infection may be strain-specific rather than genogroup dependent. J Infect Dis (2008) 1.00
The significance of circulating epithelial cells in Breast Cancer patients by a novel negative selection method. Breast Cancer Res Treat (2007) 0.99
DNA supercoiling-dependent gene regulation in Chlamydia. J Bacteriol (2008) 0.99
Bacillithiol is a major buffer of the labile zinc pool in Bacillus subtilis. Mol Microbiol (2014) 0.99
Chlamydial GroEL autoregulates its own expression through direct interactions with the HrcA repressor protein. J Bacteriol (2005) 0.98
Paneth cell alpha-defensins from rhesus macaque small intestine. Infect Immun (2004) 0.98
Structure-activity relationship studies of naphthol AS-E and its derivatives as anticancer agents by inhibiting CREB-mediated gene transcription. Bioorg Med Chem (2012) 0.98
miR-125b functions as a key mediator for snail-induced stem cell propagation and chemoresistance. J Biol Chem (2012) 0.98
A SAS-6-like protein suggests that the Toxoplasma conoid complex evolved from flagellar components. Eukaryot Cell (2013) 0.97
OMIT: a domain-specific knowledge base for microRNA target prediction. Pharm Res (2011) 0.97
Rhesus theta-defensin prevents death in a mouse model of severe acute respiratory syndrome coronavirus pulmonary disease. J Virol (2009) 0.96
Stress response gene regulation in Chlamydia is dependent on HrcA-CIRCE interactions. J Bacteriol (2004) 0.96
Role of respiratory viruses in pulmonary exacerbations in children with cystic fibrosis. J Cyst Fibros (2012) 0.96
Structure, stability and dynamics of norovirus P domain derived protein complexes studied by native mass spectrometry. J Struct Biol (2012) 0.95